3y

Eight demands to Selangor authorities on Bukit Lagong quarries – Rimba Disclosure Project

State exco Hee Loy Sian must address issues on project in 800ha of forest reserve land

3y

Food security: five action plans for Malaysia – Sim Tze Tzin

Former deputy minister of agriculture proposes land reform, adoption of technology, export focus and more

3y

Singapore seeks accountability without transparency – Howard Lee

Despite being thriving economy, government still reluctant to enact freedom of information law

3y

Does Umno’s interest trump the national interest? – Mohamed Hanipa Maidin

Holding year-end polls and putting king on notice are signs of desperation

3y

Umno’s enforced ‘indecent proposal’ – Rais Hussin Mohamed Ariff

Malaysians must oppose party’s push to hold GE15 during monsoon season

3y

Wish list for Budget 2023 on behalf of house buyers – HBA

System should be redrawn to push home construction risk on developers, not purchasers

3y

Public is stakeholder in decriminalisation of attempted suicide – Hafiz Hassan

All it takes is for Penal Code amendment bill to be passed

3y

Malaysia’s digital ambition, law misaligned – Ashraf Shaharudin

Country’s transformation efforts look good on paper, but access to information act still nowhere in sight

3y

PDRM’s unit for child sex crimes must be accountable to Parliament on its spending – Kasthuri Patto

Has RM13 mil allocation been used to employ, appoint qualified officers in D11?

3y

Safety tips and anti-scam measures for customers – banking groups

They may lead to changes in online banking experiences, expectations

3y

Who to blame for issue of nation’s unemployed graduates? – Diana Abdul Wahab

Employers should provide on-the-job training, universities should teach soft skills, opines the writer

3y

Exotic animals are not meant to be pets – CAP

Creatures often taken in by people who lack knowledge, resources, commitment to provide proper care

3y

Ban medical drug ads to curb inappropriate prescriptions – Joel Lexchin

Studies show doctors, patients too susceptible to promotions for new medicines, writes Joel Lexchin